Daré Bioscience to Participate in H.C. Wainwright 24th Annual Global Investment Conference

2 years ago

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today…

Next Generation MicroLead 2.0 Now Available with the SPRINT® PNS System

2 years ago

- Enhanced performance with increased strength - MicroLead 2.0 With >2x the cross-sectional metal as the original, the MicroLead 2.0…

Keros Therapeutics to Present at the American Society for Bone and Mineral Research 2022 Annual Meeting

2 years ago

LEXINGTON, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on…

Noah Medical to Showcase the Galaxy System™ at CHEST Annual Conference

2 years ago

Next generation, fully integrated solution for navigated bronchoscopy received rave reviews at AAIBP 2022SAN CARLOS, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE)…

Soleno Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

2 years ago

REDWOOD CITY, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing…

Tenaya Therapeutics Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for TN-301, an HDAC6 Inhibitor for Heart Failure with Preserved Ejection Fraction

2 years ago

SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a…

Keros Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

2 years ago

LEXINGTON, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on…

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

2 years ago

PHILADELPHIA, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery…

Biotimize Announces the Opening of a Fundraising Round to Build the First Biological CDMO in Brazil

2 years ago

PIRACICABA, Brazil, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Biotimize, a functional growth-stage biotechnology as a service (BaaS) company with a…